Alpha Cognition Inc. (ACOG) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
Alpha Cognition Inc. (ACOG) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Alpha Cognition Inc. (Stock Symbol: ACOG)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Annual Revenue: $100 million
generating a -4.0% net profit margin
.
Market Capitalization: $130 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Alpha Cognition Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Alpha Cognition Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Alpha Cognition Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Alpha Cognition Inc. interactive price chart and technical analysis...
Deep dive into Alpha Cognition Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Alpha Cognition Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Alpha Cognition Inc.:
P/B Ratio4.07x
Market Cap$130M
EPS$-2.78
Book Value/Share$1.99
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Alpha Cognition Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Alpha Cognition Inc.:
Operating Margin-4.9%
Net Margin-4.0%
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Alpha Cognition Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Alpha Cognition Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Alpha Cognition Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Alpha Cognition Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Alpha Cognition Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Alpha Cognition Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Alpha Cognition Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Alpha Cognition Inc.: With annual revenue of $100M, Alpha Cognition Inc. represents a smaller but potentially high-growth operation.
Income Statement ($ Millions)
Total Revenue$100M
R&D Expense$2M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding16M
Growth Metrics (YoY)
EPS Growth-5.1%
Alpha Cognition Inc. (ACOG) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Alpha Cognition Inc. stock analysis.
Loading fundamental data...
Loading Alpha Cognition Inc. comprehensive fundamental analysis and insider trading data...
Latest Alpha Cognition Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Alpha Cognition Inc. (ACOG) stock price and investment outlook.
Alpha Cognition Inc. is a commercial development stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s ...
Grapevine, Texas-- (Newsfile Corp. - April 30, 2025) - Alpha Cognition, Inc. (NASDAQ: ACOG), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May ...
August 14, 2025Alpha Cognition Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.46. Operator: Greetings, and welcome to the Alpha Cognition Earnings ...
VANCOUVER, British Columbia & DALLAS, August 04, 2025--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today ...
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Alpha Cognition Inc. (ACOG:CA) (OTCQB: ACOGF) (“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel ...
Net loss for the year ended December 31, 2024, was $14.6 million, or $ (2.02) per share, compared to a net loss of $13.8 million, or $ (3.84) per share, in 2023. About Alpha Cognition Inc.
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...
Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative ...
Alpha Cognition Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Alpha Cognition Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Alpha Cognition Inc. Stock Forecast
How accurate are Alpha Cognition Inc. stock predictions?
Our AI model demonstrates 45% historical accuracy for ACOG predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Alpha Cognition Inc. stock price forecasts?
Is Alpha Cognition Inc. a good investment in 2025?
Based on our AI analysis, Alpha Cognition Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Alpha Cognition Inc. forecasts updated?
Alpha Cognition Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Alpha Cognition Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Alpha Cognition Inc. stock.
